Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- University of Nottingham
- KINGS COLLEGE LONDON
- University of Birmingham
- Imperial College London
- King's College London
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- UNIVERSITY OF SOUTHAMPTON
- University College London
- University of Cambridge
- University of Stirling
- ; Queen Mary University of London
- CRANFIELD UNIVERSITY
- City University London
- St George's University of London
- The University of Southampton
- University of Manchester
- University of Sheffield
- 8 more »
- « less
-
Field
-
-resolution spatial transcriptomics and multiplex imaging, to turn large-scale data into actionable insights for both fundamental and translational research. About the role We are seeking a Senior
-
-resolution spatial transcriptomics and multiplex imaging, to turn large-scale data into actionable insights for both fundamental and translational research. About the role We are seeking a Senior
-
, imaging, or relevant area is essential. The post is offered on a full time (36.25 hours per week), fixed term contract until 31 December 2025. Requests for secondment from internal candidates may be
-
addresses remaining barriers to commercialisation by manufacturing and operating a containerised system with increased power and capacity (10 kW, 20 kWh) in Nepal. Prototype performance will be characterised
-
computerised psychological intervention on aspects of human cognition and emotion processing. We invite applications from individuals with a background in human experimental psychology (participant recruitment
-
translation of innovative miniature, hair-thin imaging devices we have previously developed [https://doi.org/10.1117/1.JBO.29.2.026002]. These devices are designed to enable early and accurate detection
-
This new full-time post is available from September 2025 until 31/08/2026 on a fixed-term basis. Summary of the role This role is an exciting opportunity to join the Neurodegeneration Imaging Group
-
to Treat Mitochondrial Diseases (LAC-TreatMito-UK) was established in September 2024 to deliver a national platform to translate novel treatment strategies and biomarkers into clinical trials. This platform
-
scientific boundaries and overcome hurdles. They will have experience in stem cell culture, imaging, molecular biology, genetic engineering and/or bioinformatics analysis. This will enable new approaches
-
metrology, with expertise in quantum state discrimination and parameter estimation and/or in-process metrology and conventional optical microscopy, as well as image processing and model development